Table 3.
Age group | Indications | n (%) |
---|---|---|
Neonates | – | – |
Airway obstruction | ||
- Laryngotracheal stenosis | 16(55.2%) | |
Infants | - Bilateral vocal fold paralysis | 1(3.4%) |
- Pharyngeal tumor | ||
TOTAL | 18(62%) | |
Prolonged OTI | 11(38%) | |
Airway obstruction | ||
- Laryngotracheal stenosis | 11(64.7%) | |
Pre-school age | - Laryngomalacia | 1(5.9%) |
- Laryngeal papillomatosis | 1(5.9%) | |
TOTAL | 13(76.5%) | |
SOAS | 2(11.7%) | |
Pulmonary clearance | 1(5.9%) | |
Protective tracheostomy | 1(5.9%) | |
Airway obstruction | ||
School age | - Laryngotracheal stenosis | 1(33.35%) |
- Laryngeal papillomatosis | 1(33.35%) | |
TOTAL | 2(66.7%) | |
Prolonged OTI | 1(33.3%) | |
Airway obstruction | ||
- Laryngotracheal stenosis | 4(44.5%) | |
Adolescents | - Mucopolysaccharidosis | 1(11.1%) |
- Laryngomalacia | 1(11.1%) | |
- Pharyngeal tumor | 1(11.1%) | |
TOTAL | 7(77.8%) | |
Prolonged OTI | 2(22.2%) |